γδ T cells and multiple sclerosis: Friends, foes, or both?

Autoimmunity Reviews

Volumn 10, Issue 6, 2011, Pages 364-367

  Chen, Zhihong ^a,b,d   Freedman, Mark S ^a,b,c  

^a UNIVERSITY OF OTTAWA   (Canada)

^b OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^c UNIVERSITY OF OTTAWA   (Canada)

^d LERNER RESEARCH INSTITUTE   (United States)

Author keywords

T cells; Cytotoxicity; Immunoregulation; Multiple sclerosis; NK receptors

Indexed keywords

CD16 ANTIGEN; INTERLEUKIN 17; MYELIN; NATURAL KILLER CELL RECEPTOR NKG2D;

CELL FUNCTION; CELL MIGRATION; CELL PROLIFERATION; CYTOTOXICITY; GAMMA DELTA T LYMPHOCYTE; HUMAN; IMMUNOREGULATION; INNATE IMMUNITY; MULTIPLE SCLEROSIS; NEUROTOXICITY; NONHUMAN; PATHOGENESIS; REVIEW;

ANIMALS; CENTRAL NERVOUS SYSTEM; CYTOTOXICITY, IMMUNOLOGIC; HUMANS; MULTIPLE SCLEROSIS; T-LYMPHOCYTES;

EID: 79953162539     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autrev.2010.12.005     Document Type: Review

References (41)

1. Pouly S., Antel J.P. Multiple sclerosis and central nervous system demyelination. J Autoimmun. 1999, 13:297-306.
2. Milo R., Kahana E. Multiple sclerosis: geoepidemiology, genetics and the environment. Autoimmun Rev. 2010, 9:A387-A394.
3. Rojas O.L., Rojas-Villarraga A., Cruz-Tapias P., Sanchez J.L., Suarez-Escudero J.C., Patarroyo M.A., et al. HLA class II polymorphism in Latin American patients with multiple sclerosis. Autoimmun Rev. 2010, 9:407-413.
4. Smolders J., Peelen E., Thewissen M., Menheere P., Tervaert J.W., Hupperts R., et al. The relevance of vitamin D receptor gene polymorphisms for vitamin D research in multiple sclerosis. Autoimmun Rev. 2009, 8:621-626.
5. Vosoughi R., Freedman M.S. Therapy of MS. Clin Neurol Neurosurg. 2010, 112:365-385.
6. Trapp B.D., Nave K.A. Multiple sclerosis: an immune or neurodegenerative disorder?. Annu Rev Neurosci. 2008, 31:247-269.
7. Brenner M.B., McLean J., Dialynas D.P., Strominger J.L., Smith J.A., Owen F.L., et al. Identification of a putative second T-cell receptor. Nature. 1986, 322:145-149.
8. Ciofani M., Zuniga-Pflucker J.C. Determining gammadelta versus alphabeta T cell development. Nat Rev Immunol. 2010, 10:657-663.
9. Hayday A.C. gammadelta cells: a right time and a right place for a conserved third way of protection. Annu Rev Immunol. 2000, 18:975-1026.
10. Yin Z., Zhang D.H., Welte T., Bahtiyar G., Jung S., Liu L., et al. Dominance of IL-12 over IL-4 in gamma delta T cell differentiation leads to default production of IFN-gamma: failure to down-regulate IL-12 receptor beta 2-chain expression. J Immunol. 2000, 164:3056-3064.
11. Zeine R., Pon R., Ladiwala U., Antel J.P., Filion L.G., Freedman M.S. Mechanism of gammadelta T cell-induced human oligodendrocyte cytotoxicity: relevance to multiple sclerosis. J Neuroimmunol. 1998, 87:49-61.
12. Dieli F., Poccia F., Lipp M., Sireci G., Caccamo N., Di Sano C., et al. Differentiation of effector/memory Vdelta2 T cells and migratory routes in lymph nodes or inflammatory sites. J Exp Med. 2003, 198:391-397.
13. Wucherpfennig K.W., Newcombe J., Li H., Keddy C., Cuzner M.L., Hafler D.A. Gamma delta T-cell receptor repertoire in acute multiple sclerosis lesions. Proc Natl Acad Sci U S A. 1992, 89:4588-4592.
14. Selmaj K., Brosnan C.F., Raine C.S. Colocalization of lymphocytes bearing gamma delta T-cell receptor and heat shock protein hsp65+ oligodendrocytes in multiple sclerosis. Proc Natl Acad Sci U S A. 1991, 88:6452-6456.
15. Freedman M.S., Buu N.N., Ruijs T.C., Williams K., Antel J.P. Differential expression of heat shock proteins by human glial cells. J Neuroimmunol. 1992, 41:231-238.
16. Freedman M.S., D'Souza S., Antel J.P. gamma delta T-cell-human glial cell interactions. I. In vitro induction of gammadelta T-cell expansion by human glial cells. J Neuroimmunol. 1997, 74:135-142.
17. Battistini L., Fischer F.R., Raine C.S., Brosnan C.F. CD1b is expressed in multiple sclerosis lesions. J Neuroimmunol. 1996, 67:145-151.
18. Ransohoff R.M., Kivisakk P., Kidd G. Three or more routes for leukocyte migration into the central nervous system. Nat Rev Immunol. 2003, 3:569-581.
19. Poggi A., Zocchi M.R., Costa P., Ferrero E., Borsellino G., Placido R., et al. IL-12-mediated NKRP1A up-regulation and consequent enhancement of endothelial transmigration of V delta 2+ TCR gamma delta+T lymphocytes from healthy donors and multiple sclerosis patients. J Immunol. 1999, 162:4349-4354.
20. Smith S.S., Barnum S.R. Differential expression of beta 2-integrins and cytokine production between gammadelta and alphabeta T cells in experimental autoimmune encephalomyelitis. J Leukoc Biol. 2008, 83:71-79.
21. Murzenok P.P., Matusevicius D., Freedman M.S. gamma/delta T cells in multiple sclerosis: chemokine and chemokine receptor expression. Clin Immunol. 2002, 103:309-316.
22. Saikali P., Antel J.P., Newcombe J., Chen Z., Freedman M., Blain M., et al. NKG2D-mediated cytotoxicity toward oligodendrocytes suggests a mechanism for tissue injury in multiple sclerosis. J Neurosci. 2007, 27:1220-1228.
23. Angelini D.F., Borsellino G., Poupot M., Diamantini A., Poupot R., Bernardi G., et al. FcgammaRIII discriminates between 2 subsets of Vgamma9Vdelta2 effector cells with different responses and activation pathways. Blood. 2004, 104:1801-1807.
24. Chen Z., Freedman M.S. Correlation of specialized CD16(+) gammadelta T cells with disease course and severity in multiple sclerosis. J Neuroimmunol. 2008, 194:147-152.
25. Chen Z., Freedman M.S. CD16+ gammadelta T cells mediate antibody dependent cellular cytotoxicity: potential mechanism in the pathogenesis of multiple sclerosis. Clin Immunol. 2008, 128:219-227.
26. Kaushansky N., Eisenstein M., Zilkha-Falb R., Ben-Nun A. The myelin-associated oligodendrocytic basic protein (MOBP) as a relevant primary target autoantigen in multiple sclerosis. Autoimmun Rev. 2010, 9:233-236.
27. Meinl E., Derfuss T., Krumbholz M., Probstel A.K., Hohlfeld R. Humoral autoimmunity in multiple sclerosis. J Neurol Sci 2010, 10.1016/j.jns.2010.08.009.
28. Howe C.L., Adelson J.D., Rodriguez M. Absence of perforin expression confers axonal protection despite demyelination. Neurobiol Dis. 2007, 25:354-359.
29. Hoftberger R., Aboul-Enein F., Brueck W., Lucchinetti C., Rodriguez M., Schmidbauer M., et al. Expression of major histocompatibility complex class I molecules on the different cell types in multiple sclerosis lesions. Brain Pathol. 2004, 14:43-50.
30. Bjartmar C., Wujek J.R., Trapp B.D. Axonal loss in the pathology of MS: consequences for understanding the progressive phase of the disease. J Neurol Sci. 2003, 206:165-171.
31. Darlington P.J., Podjaski C., Horn K.E., Costantino S., Blain M., Saikali P., et al. Innate immune-mediated neuronal injury consequent to loss of astrocytes. J Neuropathol Exp Neurol. 2008, 67:590-599.
32. Somers K., Govarts C., Stinissen P., Somers V. Multiplexing approaches for autoantibody profiling in multiple sclerosis. Autoimmun Rev. 2009, 8:573-579.
33. Odyniec A., Szczepanik M., Mycko M.P., Stasiolek M., Raine C.S., Selmaj K.W. Gammadelta T cells enhance the expression of experimental autoimmune encephalomyelitis by promoting antigen presentation and IL-12 production. J Immunol. 2004, 173:682-694.
34. Spahn T.W., Issazadah S., Salvin A.J., Weiner H.L. Decreased severity of myelin oligodendrocyte glycoprotein peptide 33-35-induced experimental autoimmune encephalomyelitis in mice with a disrupted TCR delta chain gene. Eur J Immunol. 1999, 29:4060-4071.
35. Ponomarev E.D., Dittel B.N. Gamma delta T cells regulate the extent and duration of inflammation in the central nervous system by a Fas ligand-dependent mechanism. J Immunol. 2005, 174:4678-4687.
36. Diaz-Bardales B.M., Novaski S.M., Goes A.E., Castro G.M., Mengel J., Santos L.M. Modulation of the severity of experimental autoimmune encephalomyelitis by gammadelta T lymphocytes activated by mycobacterial antigens. Immunol Invest. 2001, 30:245-258.
37. Jensen M.A., Dayal A., Arnason B.G. Cytokine secretion by deltagamma and alphabeta T cells in monophasic experimental autoimmune encephalomyelitis. J Autoimmun. 1999, 12:73-80.
38. Roark C.L., Simonian P.L., Fontenot A.P., Born W.K., O'Brien R.L. gammadelta T cells: an important source of IL-17. Curr Opin Immunol. 2008, 20:353-357.
39. Petermann F., Rothhammer V., Claussen M.C., Haas J.D., Blanco L.R., Heink S., et al. gammadelta T cells enhance autoimmunity by restraining regulatory T cell responses via an interleukin-23-dependent mechanism. Immunity. 2010, 33:351-363.
40. Stinissen P., Zhang J., Vandevyver C., Hermans G., Raus J. Gammadelta T cell responses to activated T cells in multiple sclerosis patients induced by T cell vaccination. J Neuroimmunol. 1998, 87:94-104.
41. Elliott C.L., El-Touny S.Y., Filipi M.L., Healey K.M., Leuschen M.P. Interferon beta1a treatment modulates TH1 expression in gammadelta+T cells from relapsing-remitting multiple sclerosis patients. J Clin Immunol. 2001, 21:200-209.